Mumps Vaccine Market is Anticipated to Grow up to USD 3.7 Billion by 2032, Driven by an Increase in the Occurrence of Infectious Diseases | Bavarian Nordic, Astellas Pharma India, CSL Limited

The global mumps vaccine market was valued at USD 2.0 billion in 2022 and it is anticipated to grow further till USD 3.7 billion by 2032, at a CAGR of 6.4% during the forecast period.

Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS24643

The immunizations used to prevent the mumps virus infection are known as mumps vaccines. The MMR vaccine, which is administered intravenously, is the vaccine of choice to protect against mumps infection. The live attenuated viruses of the three illnesses are used in this injection-based vaccine. Children under the age of 12 months and adults who are not at a high risk of exposure and transmission receive one dose of the MMR vaccination. Children between the ages of 2 and 18 as well as adults who run the risk of contracting the mumps are advised to have two doses of the vaccine.

Read more about Mumps Vaccine Market here: https://www.globalinsightservices.com/reports/mumps-vaccine-market/

Market Driver & Trends

Due to the large number of customers who are health-conscious, the pharmaceutical sector is growing and innovating to produce vaccines, which opens up opportunities for the mumps vaccine market to expand. The availability of increasing healthcare infrastructure, an increase in unmet healthcare demands, an increase in the occurrence of infectious diseases like the mumps diseases, and a surge in demand for mumps vaccines are all predicted to contribute to the growth of the mumps vaccine market.

Furthermore, the desire for better healthcare services, considerable government investments in enhancing the infrastructure for healthcare, and the growth of the medical tourism sector in emerging nations are all contributing to the significant growth of the global market for measles vaccines.

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS24643

Global Mumps Vaccine Market Segmentation

By Age Group
• Pediatric
• Adult

By Distribution Channel
• Hospitals & Clinics
• Vaccination Centers

By Region

• North America
o The U.S.
o Canada
o Mexico

• Europe
o The UK
o Germany
o France
o Spain
o Rest of Europe

• The Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific

• Rest of the World
o Latin America
o The Middle East
o Africa

Purchase This Market Research Report - https://www.globalinsightservices.com/checkout/single_user/GIS24643

Major Players in the Global Mumps Vaccines Market

The key players studied in the report are MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, and GlaxoSmithKline among others.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.